Pancreatic Quality Outcomes
Roswell Park Cancer Institute provides comprehensive, individualized gastro-intestinal cancer care for about 700 inpatient admissions and over 15,000 outpatient visits annually, including an influx of almost 1,000 new patients.
There are about 18,000 cases of colon, rectum, esophagus, stomach, liver, and pancreatic cancer diagnosed annually in New York State, with about 1,700 cases from the Western New York Region according to the New York State Tumor Registry. There are about 1,600 cases of pancreas cancer diagnosed annually in New York State, with about 240 cases from the Western New York Region according to the New York State Tumor Registry.
Our multi-disciplinary team includes an elite group of surgeons, medical oncologists, radiation oncologists, diagnostic radiologists, pathologists, physician assistants, and nurse practitioners.
Roswell Park has 20 clinical research studies that are aggressively seeking answers to the most challenging new questions in the area of Gastrointestinal and Colorectal cancers each year.
As healthcare choice becomes more patient and family-centered, access to meaningful indicators of high quality care becomes more critical in selecting your care team. The pages provide general information regarding patients who were treated at Roswell Park for pancreas cancer, the characteristics of their cancer, and their treatment. In assessing these data, it is important that the user of these data recognize the characteristics of individuals who come to a cancer center may differ somewhat from those who do not. For example, as you will see in the graphs, Roswell Park tends to see individuals who are somewhat younger than the national average and more patients with advanced stage of cancer come to Roswell Park. It is not surprising that a large cancer center attracts younger individuals and those with more advanced cancer. They may specifically choose to come to the cancer center to get more specialized care or to participate in clinical studies addressing new ways to treat aggressive cancers.

